Macleods Pharma USA Recalls Blood Pressure Tablets Due to Dissolution Issue
Macleods Pharma USA is recalling blood pressure medication tablets nationwide after failing dissolution specifications.
Macleods Pharma USA, Inc. is recalling Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide Tablets (40 mg/10 mg/12.5 mg). The prescription medication was packaged in 30-count and 90-count bottles.
The recall was issued because the tablets failed dissolution specifications during testing. When a drug fails dissolution testing, it may not dissolve properly in the body as intended.
The products were distributed nationwide across the United States. The recall is classified as a Class II recall by the U.S. Food and Drug Administration (FDA).
What to do
- Stop using the recalled medication after consulting with your doctor or pharmacist.
- Contact your healthcare provider to secure an alternative treatment option before stopping prescription blood pressure drugs.
- Reach out to Macleods Pharma USA, Inc. or the FDA for additional information regarding this recall.
At a glance
| Agency | U.S. Food and Drug Administration (FDA) |
|---|---|
| Recall number | D-0077-2027 |
| Date | 2026-11-04 |
| Company | MACLEODS PHARMA USA, INC, Princeton, NJ |
| Severity | Class II |
| Quantity | 3528 30-count and 216 90-count bottles |
| Where sold | Nationwide in the USA |
| Lot codes / identifiers | Lot #: a) 12251163A, Exp 05-31-2027; b) 12251163B, Exp 05-31-2027 |
Source: official FDA notice. This summary was written by 365 News from the official notice. Details can change; check the notice before acting.